Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

3-year COAPT results bolster MitraClip’s success

Results from the COAPT study continue to roll in, and it was all positive news for the MitraClip team at the TCT conference in San Francisco this month.

FDA greenlights early feasibility study for less-invasive TMVR system

Medtronic announced Sept. 27 that it had received FDA approval to launch an early feasibility study for its Intrepid TMVR system using a minimally invasive transfemoral access approach.

Thumbnail

Failed TAVR more common in women, those with PAD

The incidence of aborted procedures during transcatheter aortic valve replacement is falling, according to work published in JACC: Cardiovascular Interventions, but centers with low institutional TAVR volume still struggle to keep up with bigger hospitals’ success.

Thumbnail

Fluoroquinolone use predicts aortic, mitral regurgitation

People who currently take or have recently taken fluoroquinolones face higher odds of aortic and mitral regurgitation, according to a report out of Canada.

Thumbnail

Tackling the Undertreatment of Aortic Stenosis in the U.S.

The problem is fixable, but it will take hard work, says one Duke University researcher. And cardiologists could be the key. 

Thumbnail

Transcarotid Access: The Future of Non-femoral TAVR?

The transcarotid approach to TAVR is becoming more common, according to research presented at TVT.19.

Thumbnail

As Surgery Gives Way to Transcatheter Procedures, Is the Cardiology Cash Cow in Jeopardy?

With minimally invasive structural procedures crowding out their surgical counterparts, how are physicians and hospitals preparing for the new reality? 

Thumbnail

FDA Expands Indication for TAVR to Low-risk Patients

The U.S. now will allow  TAVR  for patients at low risk for death or major complications during open-heart surgery.

Displaying 713 - 720 of 2332

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.